Maviret is used to treat chronic hepatitis C (hep C), a viral infection of the liver. It is a combination of 2 medicines, glecaprevir and pibrentasvir that work together to stop the hep C virus from multiplying and infecting new cells. This allows the infection to be cleared from your body. Maviret works against all genotypes of hepatitis C virus. Read more about hepatitis C.
Evidence shows that 98% of people who take Maviret as directed, and who are new to treatment and without cirrhosis of the liver, can expect to be cured of their hep C. Cure means the hep C virus is not found in your blood 3 months after treatment ends.
Maviret will not prevent you from getting hep C in the future. You should take precautions to avoid re-infection.